#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Acute lymphocytic leukaemia recurrent Cystic fibrosis respiratory infection suppression B precursor type acute leukaemia Neovascular age-related macular degeneration Waldenstrom's macroglobulinaemia Leukocyte adhesion deficiency Deafness neurosensory Rhabdomyosarcoma recurrent Adenoid cystic carcinoma Neuroendocrine carcinoma of the skin Adenocarcinoma gastric Loss of consciousness Li-Fraumeni syndrome Acquired C1 inhibitor deficiency More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Trials in Disease Chronic granulomatous disease – Diagnostics Turner’s syndrome – Treatment Synovial sarcoma recurrent – Diagnostics Synovial sarcoma recurrent – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Burkitt’s lymphoma – Treatment Nephroblastoma – Diagnostics Primary biliary cholangitis – Trials in Disease Sarcoidosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Panobinostat ROC-101 HYDROCHLORIDE Concizumab Dopamine Hydrochloride 19Cp02 Ciclosporin Myrrh Xxb750 Minzasolmin Olaptesed Pegol Dried Ferrous Sulfate Cendakimab KETOROLAC Sebetralstat Verapamil Omp64 Benzalkonium Chloride Iph5201 Pp1493 NERANDOMILAST More therapies…

    Learn about Your Condition

    Cirrhosis alcoholic Tonsillitis Dysmenorrhoea Malignant melanoma stage II Pancreatic fistula Proteus syndrome Psychotic behaviour Mitral valve incompetence Pneumococcal infection Infantile apnoea Bacteraemia Gastrointestinal disorder Desmoid tumour Infertility Mastocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fondation A De Rothschild

Fondation A De Rothschild

25 Rue Manin, Paris, 75019, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Cyprus Czechia Denmark Finland +9

  • Study on the Effectiveness of Tocilizumab, Methylprednisolone, and Prednisone for Patients with Acute Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Prednisone
    • Tocilizumab
    France

  • Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Frexalimab
    Belgium Bulgaria Czechia France Germany Greece +7

  • Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Drugs:
    • Tolebrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study on the Effectiveness of Dornase Alfa for Improving Blood Flow in Patients with Ischemic Stroke Eligible for Thrombectomy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Dornase Alfa
    France

  • Study of cangrelor with mechanical thrombectomy in patients with acute ischemic stroke selected by perfusion imaging

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cangrelor Tetrasodium
    France

  • Study on Milrinone Infusion for Treating Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Milrinone
    France

  • Study on Izokibep for Patients with Non-infectious Uveitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Chorioretinitis
    • Uveitis
    Investigated Drugs:
    • Izokibep
    Austria Czechia France Germany Italy Spain

  • Study of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson’s Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepato-lenticular degeneration
    Investigated Drugs:
    • Trientine Dihydrochloride
    Denmark France Germany Poland

  • Study on the Effectiveness and Safety of STN1010904 Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    • Corneal dystrophy
    Investigated Drugs:
    • Sirolimus
    France
Previous Page
1 … 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!